Clinical trial

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

NCT04665986

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Navelbine Normalized identity: NavelbineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Docetaxel Normalized identity: docetaxelView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-03-01

PhasePHASE3

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

NavelbineDRUG · verified · RxNorm: Navelbine

DocetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Zhejiang Cancer Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04665986 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.